Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ascorbic acid (vitamin C) and thiamine (vitamin B1) is a combination of two essential water-soluble vitamins. This combination is used primarily to treat or prevent deficiencies in these vitamins due to poor diet, certain illnesses, alcoholism, or during pregnancy. Both are important cofactors in cellular metabolism and energy production. Ascorbic acid acts as an antioxidant and supports immune function, collagen synthesis, and iron absorption. Thiamine is crucial for carbohydrate metabolism and neural function. In clinical research settings—particularly in critical care—the combination has been studied for adjunctive therapy in sepsis and septic shock based on the hypothesis that they may synergistically restore mitochondrial function, reduce oxidative stress, modulate inflammation, and improve organ dysfunction[1][5][7]. However, recent evidence suggests that while both have biological plausibility for benefit in critical illness (notably sepsis), the combination does not consistently improve survival compared to standard care or thiamine alone[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ascorbic acid + thiamine.